Showing results (251-260 of 590) with videos related to
Sort By:
Pageof 59
Respiratory Research|January 18, 2024
A formula for predicting emphysema extent in combined idiopathic pulmonary fibrosis and emphysemaAthol U Wells, Joseph Jacob, Nicola Sverzellati, et al.BMJ Open Respiratory Research|September 1, 2018
Investigating the effects of nintedanib on biomarkers of extracellular matrix turnover in patients with IPF: design of the randomised placebo-controlled INMARK®trialToby M Maher, Susanne Stowasser, Yasuhiko Nishioka, et al.Chest|March 26, 2022
The Role of Genetic Testing in Pulmonary Fibrosis: A Perspective From the Pulmonary Fibrosis Foundation Genetic Testing Work GroupChad A Newton, Justin M Oldham, Carolyn Applegate, et al.Thorax|June 10, 2022
Genome-wide association study across five cohorts identifies five novel loci associated with idiopathic pulmonary fibrosisRichard J Allen, Amy Stockwell, Justin M Oldham, et al.Journal of Clinical Medicine|November 26, 2020
Automated CT Analysis of Major Forms of Interstitial Lung DiseaseMarlee S Crews, Brian J Bartholmai, Ayodeji Adegunsoye, et al.Respiratory Research|March 17, 2021
Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseasesVincent Cottin, Luca Richeldi, Ivan Rosas, et al.Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|June 2, 2020
A 12-week combination of clarithromycin and prednisone compared to a 24-week prednisone alone treatment in cryptogenic and radiation-induced organizing pneumoniaNicolas Petitpierre, Vincent Cottin, Sylvain Marchand-Adam, et al.BMC Cardiovascular Disorders|April 2, 2009
Right-to-left shunt with hypoxemia in pulmonary hypertensionJean-Frédéric Vodoz, Vincent Cottin, Jean-Charles Glérant, et al.ERJ Open Research|July 23, 2024
Circulating biomarkers and progression of idiopathic pulmonary fibrosis: data from the INMARK trialToby M Maher, R Gisli Jenkins, Vincent Cottin, et al.Plos One|June 2, 2012
Professional exposure to goats increases the risk of pneumonic-type lung adenocarcinoma: results of the IFCT-0504-Epidemio studyDelphine Lutringer-Magnin, Nicolas Girard, Jacques Cadranel, et al.Pageof 59